
Our lab had a great time at the Society for Neuro -Oncology (SNO) Annual Meeting in Philadelphia this past weekend. Lab members Kirit Singh, Kenan Zhang, Jodie Jepson, Anna Corcoran, Andrew Kurlich, Julia Louw, and Emma Pristo presented their findings as research posters and rapid-oral presentations. In addition, Julia presented her work on prediction of glioblastoma recurrence using H&E histopathology and xenium spatial transcriptomics as a formal abstract presentation. Lastly, Dr. Khasraw led a team of panelists in a discussion on brain tumor window of opportunity trials.

This weekend was an amazing opportunity to showcase our work, exchange ideas, and learn about other exciting developments across the field.
Please see below for individual presentation topics.
Very proud of this team for all their hard work! See you next year, SNO!
Julia:
- Oral Abstract: Spatially informed machine learning predicts glioblastoma recurrence timing from routine histopathology
- Poster: Spatial transcriptomics reveals myeloid–stromal reorganization and T-cell niche loss at oligodendroglioma recurrence
Kenan:
- Rapid Oral & Poster: What Drives Long-Term Survival in Glioblastoma? A Multi-Omic Analysis of Distinct Survival Phenotypes
- Poster: Localized IL-12/anti-PD-1 oncolytic HSV-1 therapy induces CSF immune remodeling in recurrent glioblastoma
Emma:
- Rapid Oral & Poster: Genomic Response Evaluation During Treatment and Longitudinal Profiling (GRETeL): Linking ctDNA Dynamics, Systemic Immunity, Radiomics, and Clinical Outcomes in Glioblastoma
Jodie:
- Rapid Oral & Poster: Spatial tumor–immune features of primary and recurrent glioblastoma
Anna:
- Rapid Oral & Poster: Perioperative PD-1/LAG-3 Inhibition Promotes Immune Remodeling in Newly Diagnosed Glioblastoma: Early Findings from the Stage 1 of the International Randomized GIANT Biopsy-Treat-Resect Clinical Trial
- Poster: A multicenter trial to identify optimal atezolizumab biomarkers in recurrent glioblastoma: the MOAB trial
Andrew:
- Rapid Oral & Poster: A Universal CD4+ Epitope Enhances Cytotoxic T-cell Priming and Memory in Glioblastoma Peptide Vaccination: Results of the ETAPA Clinical Trial
- Poster: Toward Tumor Reactive TIL Therapy for Glioblastoma: Patient-Matched Autologous Co-Culture Testing of Manufactured TIL Products
Kirit:
- Rapid Oral & Poster: A randomized surgical window of opportunity study evaluating fluoxetine and temozolomide in recurrent high-grade glioma





